Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Thanks for your generous response about the dosing and agree that it will be a work in progress and of course we are all interested to see how this shakes out.

Agreed the Mayo collaboration much more impt than the orphan designation, and also that the grant itself is of no significance, win or lose, what matters is working with a team of dedicated pancreatic CA specialists who see a lots of patients and run a lot of trials.

Phase 2 ovarian, pancreatic, renal- we are about to learn if Kevetrin actually works!